Effect of canonical aryl hydrocarbon receptor pathway inhibitor on human umbilical vein endothelial cells

ABSTRACT: To study the effect of blockade of canonical aryl hydrocarbon receptor (AHR) pathway in human endothelial cells, we treated human umbilical vein endothelial cells (HUVECs) with a canonical AHR inhibitor, Stemreginin 1 (SR1) and performed bulk RNAseq analysis.

ORGANISM(S): Homo sapiens

PROVIDER: GSE251861 | GEO | 2024/07/01

REPOSITORIES: GEO